Practical considerations in medical cannabis administration and dosing.
Eur J Intern Med. 2018.
PMID: 29307505
Review.
Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1998 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 0 |
Search Results
10 results
Results by year
Citations
1
article
found by citation matching
Search results
Page 1
Practical considerations in medical cannabis administration and dosing.
Eur J Intern Med. 2018 Mar;49:12-19. doi: 10.1016/j.ejim.2018.01.004. Epub 2018 Jan 4.
Eur J Intern Med. 2018.
PMID: 29307505
Review.
With the advent of pharmaceutical cannabis-based medicines (Sativex/nabiximols and Epidiolex), and liberalisation of access in certain nations, this ignorance of cannabis pharmacology and therapeutics has become untenable. In this article, the authors endeavour to p …
With the advent of pharmaceutical cannabis-based medicines (Sativex/nabiximols and Epidiolex), and liberalisation of access in certai …
"Is medical cannabis safe for my patients?" A practical review of cannabis safety considerations.
Eur J Intern Med. 2021 Jul;89:10-18. doi: 10.1016/j.ejim.2021.05.002. Epub 2021 May 31.
Eur J Intern Med. 2021.
PMID: 34083092
Free article.
Review.
Medical cannabis use is increasing worldwide. Clinicians are commonly asked by patients to provide guidance on its safety and efficacy. ...We aim to address this issue by answering two pertinent clinician safety questions: 1 Can medical cannabis be saf …
Medical cannabis use is increasing worldwide. Clinicians are commonly asked by patients to provide guidance on its safety and …
Cannabinoids, Insomnia, and Other Sleep Disorders.
Chest. 2022 Aug;162(2):452-465. doi: 10.1016/j.chest.2022.04.151. Epub 2022 May 7.
Chest. 2022.
PMID: 35537535
Review.
Sleep disturbances are often cited as a primary reason for medicinal cannabis use, and there is increasing clinical interest in the therapeutic potential of cannabinoids in treating sleep disorders. ...This critical review summarizes the current evidence for the use of can …
Sleep disturbances are often cited as a primary reason for medicinal cannabis use, and there is increasing clinical interest in the t …
Medical Cannabis in Oncology: a Valuable Unappreciated Remedy or an Undesirable Risk?
Curr Treat Options Oncol. 2021 Jan 13;22(2):16. doi: 10.1007/s11864-020-00811-2.
Curr Treat Options Oncol. 2021.
PMID: 33439370
Review.
In light of the growing popularity of cannabis usage, it is highly essential that, in the near future, the medical community will be able to provide practical recommendations and explicit guidelines, including doses, and that cannabinoid concentrations …
In light of the growing popularity of cannabis usage, it is highly essential that, in the near future, the medical community w …
Cannabis Science and Therapeutics: An Overview for Clinicians.
J Clin Pharmacol. 2024 May;64(5):499-513. doi: 10.1002/jcph.2400. Epub 2024 Jan 17.
J Clin Pharmacol. 2024.
PMID: 38145388
Review.
This narrative review provides a comprehensive overview of the science behind the medical use of cannabis, focusing on the medical evidence for commonly treated conditions. In addition, the review addresses the practical considerations of using …
This narrative review provides a comprehensive overview of the science behind the medical use of cannabis, focusing on the …
Review of cannabis use and propofol anesthesia: recent insights and clinical implications.
Curr Opin Anaesthesiol. 2025 Oct 1;38(5):660-668. doi: 10.1097/ACO.0000000000001548. Epub 2025 Jul 1.
Curr Opin Anaesthesiol. 2025.
PMID: 40583839
Review.
PURPOSE OF REVIEW: We examine recent evidence and clinical implications of pharmacological interactions between cannabis and propofol, perioperative considerations for propofol administration, including dosing adjustments and cardiovascular effects, su …
PURPOSE OF REVIEW: We examine recent evidence and clinical implications of pharmacological interactions between cannabis and propofol …
[Cannabis--Position Paper of the German Respiratory Society (DGP)].
Pneumologie. 2016 Feb;70(2):87-97. doi: 10.1055/s-0042-100040. Epub 2016 Mar 2.
Pneumologie. 2016.
PMID: 26935046
Free article.
German.
There is only little scientific evidence for medical benefits through cannabis as a remedy; systematic research of good quality, in particular prospective, randomised, placebo-controlled double-blinded studies are rare. The medical societies signing this posi …
There is only little scientific evidence for medical benefits through cannabis as a remedy; systematic research of good qualit …
Clinical trials with cannabis medicines-guidance for ethics committees, governance officers and researchers to streamline ethics applications and ensuring patient safety: considerations from the Australian experience.
Trials. 2020 Nov 17;21(1):932. doi: 10.1186/s13063-020-04862-6.
Trials. 2020.
PMID: 33203469
Free PMC article.
With cannabis medicines now obtaining legal status in many international jurisdictions (generally on the authorisation of a medical professional), a rapid increase in consumer demand for access to cannabis as a therapeutic option in the treatment and manageme …
With cannabis medicines now obtaining legal status in many international jurisdictions (generally on the authorisation of a medica …
Cannabis and intractable chronic pain: an explorative retrospective analysis of Italian cohort of 614 patients.
J Pain Res. 2017 May 22;10:1217-1224. doi: 10.2147/JPR.S132814. eCollection 2017.
J Pain Res. 2017.
PMID: 28579820
Free PMC article.
In recent years, a number of nations have introduced specific laws to allow patients to use cannabis preparations to treat a variety of medical conditions. In 2015, the Italian government authorized the use of cannabis to treat several diseases, including chr …
In recent years, a number of nations have introduced specific laws to allow patients to use cannabis preparations to treat a variety …
[Driving fitness/driving capacity of patients treated with methadone].
Schweiz Med Wochenschr. 1998 Oct 10;128(41):1538-47.
Schweiz Med Wochenschr. 1998.
PMID: 9816613
German.
In the urine samples of approximately 2/3 of the test persons, evidence was found for multiple drug use together with other psychotropic substances, the most frequent (14) being cannabis metabolites. Referring to their driving practices, a mere 4 out of 29 drivers h …
In the urine samples of approximately 2/3 of the test persons, evidence was found for multiple drug use together with other psychotropic sub …
Cite